Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin versus warfarin for symptomatic isolated calf deep vein thrombosis
ACTRN12610000806066Phase 4Terminated
- Sponsor
- University of New South Wales
- Start
- Jun 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in deep vein thrombosis (DVT) comparing Enoxaparin only with Usual care enoxaparin bridge to warfarin (2 arms). Primary endpoint: Time in therapeutic range / therapeutic treatment exposure. Started Jun 2010; status: terminated.
02
Drugs
enoxaparinwarfarin
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on ACTRN12610000806066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000806066.